University of Patras
Φαρμακολογικός χαρακτηρισμός ουσιών που μεταβάλλουν τα επίπεδα H2S: μεταβολές στην κυτταρική σηματοδότηση και επιπτώσεις στις κυτταρικές λειτουργίες
Abstract
dc:descriptionHydrogen sulfide (H2S), is a signaling molecule with multiple modes of action andbiological functions. It regulates physiological processes such as vascular tone,angiogenesis and neurotransmission, but deregulation of its production is implicatedin pathologies such as neurodegeneration, cancer and endocrine disorders.Endogenous hydrogen sulfide is in major part generated by two pyridoxal-5´-phosphate-dependent enzymes, cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS), both using L-cysteine as the main substrate. Another enzymaticpathway involves the conversion of 3-mercaptopyruvate to hydrogen sulfide andpyruvate by 3-mercaptopyruvate sulphurtransferase, 3MST. The lack of usefulpharmacological research tools, such as potent and selective inhibitors for eachenzyme, or stimulators of the enzyme (i.e. distinct from H2S donors), has a negativeimpact on research addressing the translational potential of hydrogen sulfide and themechanism of its action.In order to fill this gap, we carried out an in vitro screening, using in-house purifiedrecombinant enzymes, of several new compounds that have been specificallysynthesized as potential inhibitors for CBS and CSE. We also screened a collection of1280 clinically used drugs and well-annotated pharmacological compounds (LOPAClibrary). After that we conducted a more extensive pharmacological characterizationof selected compounds in order to establish their selectivity.We found that the newly synthesized compounds, Hydrazino-glycine and Hydrazino-L-alanine, inhibit both CBS and CSE, displaying limited selectivity, so that they couldbecome the base for synthesis of more selective inhibitors of these enzymes. We alsoobserved that the IC50 of AVG for CSE is 1μM, making AVG the most potentavailable inhibitor for this enzyme. Initial hits from the LOPAC library screeningwere further examined. Our results showed that doxycycline and demeclocyclinecould be used as useful (in low concentrations selective) inhibitors for 3MST,especially since there are currently no selective annotated inhibitors for this enzyme.An additional purpose of the current study was to investigate the effect of theallosteric CBS activator S-adenosyl-L-methionine (SAM) on the proliferation of theCBS-hyperexpressing colon cancer cell line HCT116. The non-transformed, nontumorigeniccolon epithelial cell line NCM356 was used as control. SAM exertedtime- and concentration-dependent modulatory effects on cell proliferation. At 0,1–1mM SAM increased HCT116 proliferation between 0 and 12 h, while the highestSAM concentration (3mM) inhibited proliferation. These short-term stimulatoryeffects of SAM were attenuated by the CBS inhibitor AOAA or by stable silencing ofCBS via shRNA. In contrast, the inhibitory effects of SAM on cell proliferation wasunaffected by CBS inhibition or CBS silencing. In addition, SAM failed to exert thestimulatory effects on NCM356 proliferation, although the SAM-induced suppressionof NCM356 proliferation was maintained. We conclude that a significant portion ofSAM’s pro- proliferative effects seen in the current study are, in fact, related toincreased endogenous H2S production via CBS; however, the long-term growthinhibitory/antitumor effects of SAM involve CBS/H2S-independent mechanisms.Collectively, our study resulted in a) the identification and characterization ofcompounds, among them approved drugs (tetracyclines), as selective (in certainconcentrations) inhibitors of H2S-synthesizing enzymes, thus providing initialstructures for optimization of their potency and selectivity in the future, and b) theextensive characterization of the role of the allosteric CBS activator SAM, on theproliferation of the CBS-hyperexpressing colon cancer cells.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Asimakopoulou, Antonia
- Ασημακοπούλου, Αντωνία
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40334